JAK2-IN-22
JAK2-IN-22 is a bicyclic urea compound with potent binding inhibitory activity against wild-type and V617F mutant JH2 kinases (IC50 ≤ 10 nM). JAK2-IN-22 can be used in research related to various diseases including cancer.
For research use only. We do not sell to patients.
- CAS No.: 3057053-13-8
- Formula: C33H34FN7O5
- Molecular Weight:627.67
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
JAK2wt |
JAK2V617F |
In Vitro
JAK2-IN-22 (Example 2) exhibits potent binding inhibitory activity against wild-type/V617F mutant JH2 (IC50 ≤ 10 nM), but shows almost no binding inhibitory effect on JH1 and no enzymatic inhibitory activity against V617F JAK2 (IC50 > 1000 nM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3057053-13-8
-
Molecular Weight 627.67
-
Formula C33H34FN7O5
-
SMILES
O=C1N([C@H]2C[C@@H](CC2)NC(OC)=O)C3=CC(NC4=CC(C5=CC(C#N)=CC=C5)=CC(NC(C6(CCOCC6)F)=O)=C4)=NC=C3N1C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)